SYN-TECH Chem. & Pharm. , Ltd. Overview
Latest ROE for SYN-TECH Chem. & Pharm. , Ltd.: 12.86% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow12.86%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for 1777.TWO is 12.86%. That is above the sector sector average of 11.75%. Investors often review this figure alongside SYN-TECH Chem. & Pharm. , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 1777.TWO currently prints 12.86% for ROE, while the sector average sits near 11.75%. That is roughly 9.4% above the sector mean. Large gaps often invite a closer look at SYN-TECH Chem. & Pharm. , Ltd.'s growth, margins, and balance sheet.
Return on Equity shows how effectively SYN-TECH Chem. & Pharm. , Ltd. converts resources into returns. At 12.86%, 1777.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 1777.TWO's ROE (12.86%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
